The feasibility of folate receptor alpha- and HER2-targeted intraoperative fluorescence-guided cytoreductive surgery in women with epithelial ovarian cancer: A systematic review

CONCLUSION: FGCS targeting either HER2 or FRα appears to be feasible in both EOC animal models and patients with EOC. FGCS is a promising technique, but further research is warranted to validate these results and particularly study the survival benefit.PMID:34053747 | DOI:10.1016/j.ygyno.2021.05.017

Source: Gynecologic Oncology - May 31, 2021 Category: Cancer & Oncology Authors: J M de Jong J P Hoogendam A J A T Braat R P Zweemer C G Gerestein Source Type: research